These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 25438283

  • 1. Measurement of portal pressure.
    Abraldes JG, Sarlieve P, Tandon P.
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [Abstract] [Full Text] [Related]

  • 2. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U, Bellis L, Puoti C, Burroughs AK.
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [Abstract] [Full Text] [Related]

  • 3. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [Abstract] [Full Text] [Related]

  • 4. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
    Reverter E, Blasi A, Abraldes JG, Martínez-Palli G, Seijo S, Turon F, Berzigotti A, Balust J, Bosch J, García-Pagán JC.
    Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 6. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.
    Triantos CK, Nikolopoulou V, Burroughs AK.
    Aliment Pharmacol Ther; 2008 Oct 15; 28(8):943-52. PubMed ID: 18627364
    [Abstract] [Full Text] [Related]

  • 7. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S, Triantos C, Theodoropoulos J, Vlachogiannakos J, Kougioumtzan A, Papatheodoridis G, Tzourmakliotis D, Karamanolis D, Burroughs AK, Archimandritis A, Raptis S, Avgerinos A.
    J Hepatol; 2009 Sep 15; 51(3):468-74. PubMed ID: 19616339
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen E.
    Scand J Gastroenterol; 2012 Apr 15; 47(4):467-74. PubMed ID: 22401315
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.
    J Hepatol; 2009 Aug 15; 51(2):279-87. PubMed ID: 19501930
    [Abstract] [Full Text] [Related]

  • 15. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S, Bendtsen F.
    Ugeskr Laeger; 2010 Dec 06; 172(49):3411-3. PubMed ID: 21129318
    [Abstract] [Full Text] [Related]

  • 16. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug 06; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C, Graupera I, Aracil C, Alvarado E, Miñana J, Puente Á, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepción M, Poca M, Torras X, Reñe JM, Guarner C.
    Hepatology; 2017 May 06; 65(5):1693-1707. PubMed ID: 28100019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.